These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3819462)

  • 21. [Leishmaniasis and HIV infection].
    Oliván A; Reparaz J; Uriz J; Solá J
    Enferm Infecc Microbiol Clin; 1989 Jan; 7(1):60. PubMed ID: 2490651
    [No Abstract]   [Full Text] [Related]  

  • 22. [Infection by HTLV-1 in heroin addicts in Barcelona].
    Soriano V; Tor J; Ribera A; Muga R
    Med Clin (Barc); 1989 May; 92(20):799. PubMed ID: 2796428
    [No Abstract]   [Full Text] [Related]  

  • 23. [Erythroderma as presentation form of visceral leishmaniasis in a patient with human immunodeficiency virus infection].
    Belda Mira A; Pascual Izuel JM; Prats Mañez A; García Castell J
    Rev Clin Esp; 1992 Nov; 191(8):454. PubMed ID: 1488524
    [No Abstract]   [Full Text] [Related]  

  • 24. Association of visceral leishmaniasis and human immunodeficiency virus infections.
    Alvar J; Blazquez J; Najera R
    J Infect Dis; 1989 Sep; 160(3):560-1. PubMed ID: 2760511
    [No Abstract]   [Full Text] [Related]  

  • 25. [Secondary amyloidosis with irreversible acute renal failure caused by visceral leishmaniasis in a patient with AIDS].
    Navarro M; Bonet J; Bonal J; Romero R
    Nefrologia; 2006; 26(6):745-6. PubMed ID: 17227255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Allopurinol in the treatment of HIV-infected patients with visceral leishmaniasis].
    Mora A; Borrell M; Galofré J; Grau JM
    Enferm Infecc Microbiol Clin; 1990 Apr; 8(4):257-8. PubMed ID: 2090223
    [No Abstract]   [Full Text] [Related]  

  • 27. [Visceral leishmaniasis with intestinal involvement in a patient with AIDS].
    García M; de Andrés RM; Santillana T; Orejas B
    Enferm Infecc Microbiol Clin; 1994 Oct; 12(8):415-6. PubMed ID: 7981299
    [No Abstract]   [Full Text] [Related]  

  • 28. Diffuse cutaneous leishmaniasis with visceral dissemination in an AIDS patient in Guadeloupe, West Indies.
    Cnudde F; Raccurt C; Boulard F; Terron-Aboud B; Nicolas M; Juminer B
    AIDS; 1994 Apr; 8(4):559-60. PubMed ID: 8011265
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute abdominal pain due to visceral Leishmaniasis in an AIDS patient].
    Pascual I; Monasterio S; González-Obeso E; Corripio Sánchez R; Martínez Alegre J; Pérez-Robledo JP
    Rev Esp Enferm Dig; 2007 Jan; 99(1):51-2. PubMed ID: 17371134
    [No Abstract]   [Full Text] [Related]  

  • 30. Visceral leishmaniasis (kala azar) in a patient with AIDS.
    Smith D; Gazzard B; Lindley RP; Darwish A; Reed C; Bryceson AD; Evans DA
    AIDS; 1989 Jan; 3(1):41-3. PubMed ID: 2496712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-kala-azar dermal leishmaniasis (PKDL), HIV and pulmonary tuberculosis.
    Das VN; Pandey K; Verma N; Bimal S; Lal CS; Singh D; Das P
    Natl Med J India; 2010; 23(2):88-9. PubMed ID: 20925205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral leishmaniasis recrudescence in a patient with AIDS.
    Antunes F; Carvalho C; Tavares L; Botas J; Forte M; del Rio AM; Dutschmann L; Costa A; Abranches P; Pereira CS
    Trans R Soc Trop Med Hyg; 1987; 81(4):595. PubMed ID: 3445340
    [No Abstract]   [Full Text] [Related]  

  • 33. [Visceral leishmaniasis and AIDS. Report of 2 cases with cutaneous dissemination].
    Belda Mira A; Díaz Sánchez F; Martínez García B; Gonzalvo Bellver E; Antón Crespo V; Redón Mas J
    An Med Interna; 1994 Aug; 11(8):398-400. PubMed ID: 7772689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visceral leishmaniasis and AIDS.
    de Gorgolas M; Miles MA
    Nature; 1994 Dec 22-29; 372(6508):734. PubMed ID: 7997260
    [No Abstract]   [Full Text] [Related]  

  • 35. Subclinical hypothyroidism in a patient affected by advanced AIDS and visceral leishmaniasis.
    Ranieri R; Veronelli A; Santambrogio C; Colombo L; Pontiroli AE
    Scand J Infect Dis; 2005; 37(11-12):935-7. PubMed ID: 16308238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus].
    Ribelles N; Casals A; Vallés J; Clotet B
    Med Clin (Barc); 1989 May; 92(17):679. PubMed ID: 2747338
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cutaneo-visceral leishmaniasis: a new opportunistic infection in patients infected by HIV].
    Botella Estrada R; Sanmartín Jiménez O; Febrer Bosch MI; Aliaga Boniche A; Salavert Lleti M; Roig Rico P; Nieto García A; Navarro Ibañez V
    Med Cutan Ibero Lat Am; 1990; 18(2):119-23. PubMed ID: 2214938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fatal visceral leishmaniasis associated with acquired immunodeficiency syndrome: report of a case with necropsy findings and immunohistochemical study].
    Ramos CC; Duarte MI; Ramos AM
    Rev Soc Bras Med Trop; 1994; 27(4):245-50. PubMed ID: 7855368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Visceral leishmaniasis of fatal outcome associated with HTLV-III infection].
    Medrano González F; Alemán Lorenzo A; Beato Pérez JL
    Med Clin (Barc); 1986 Nov; 87(18):780-1. PubMed ID: 3796128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.